Mr. Ronald Loucks reports

NEXGENRX ANNOUNCES 2023 YEAR END RESULTS WITH SOLID REVENUE GROWTH, CONTINUING POSITIVE EBITDA

NexgenRx Inc. has released its annual financial results for the financial year ended Dec. 31, 2023, with continued revenue growth to $3,573,751 for the quarter and $13,846,329 year to date. Annual EBITDA (earnings before interest, taxes, depreciation and amortization) was $1,067,247.

Despite economic challenges in 2023, with most leading economies experiencing significant increases in inflation and suffering the negative impact of the rising interest rates designed to quell it, the company continued to show solid revenue growth in its business. Two thousand twenty-three results showed revenue growth of $1,065,101 or 8.33 per cent over the prior year, with a positive EBITDA of $1,067,247. The company's cash position remained strong at $1,876,765, after cash dividend payouts of $351,679 to the common shareholders in June, 2023.

Ron Loucks, president and chief executive officer, stated: "With various investments that the company made upfront to develop and maintain customer relationships, together with distribution of dividends, these results are a strong statement that reflects the company's capability of generating free cash flow. Two thousand twenty-three marks the 20th anniversary of the incorporation of NexgenRx. This significant milestone is particularly gratifying to me as the company continues to expand its reach in the marketplace with new and innovative product solutions. As always, I would like to acknowledge our loyal shareholders [and] board of directors for their dedication, advice and counsel, our hard-working staff, and, most importantly, the continuous support and trust of our customers, in their commitment to the NexgenRx group of companies."

About NexgenRx Inc.

NexgenRx is Canada's only independent full-service third party administrator and technology solutions provider, offering proprietary full front-end, eligibility, enrolment, hour bank and mobile access capabilities, together with state-of-the-art claims adjudication and full provider network coverage. These combined capabilities allow NexgenRx to provide plan sponsors, sophisticated administration and health benefit technology applications in a cost-effective SaaS (software-as-a-service) model.

NexgenRx is committed to building partnerships with organizations looking to exceed the expectations of their clients and plan members and deliver superior administration and claims processing solutions at a competitive cost.

We seek Safe Harbor.